🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: GM1 gangliosidosis is a disorder that destroys nerve cells. It...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2019-08-19
Trial ID
NCT03952637
Treatments Being Tested
Primary and secondary brain tumors, the leading cause of death from cancer ...
Status
Recruiting
Location
Service de Neurochirurgie - Hôpital de la Pitié Salpêtrière
Start Date
2024-03-26
Trial ID
NCT06314607
Treatments Being Tested
This phase Ib/II trial tests the safety, side effects, best dose and how we...
Status
Recruiting
Location
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Start Date
2026-10-13
Trial ID
NCT07069699
The TOTEM study is a single-center study designed to evaluate the performan...
Status
Recruiting
Location
Toulouse Hospital
Start Date
2025-02-12
Trial ID
NCT06482463
Treatments Being Tested
Spinocerebellar ataxias (SCA) are genetic neurological diseases that cause ...
Status
Recruiting
Location
University of California Los Angeles
Start Date
2010-04
Trial ID
NCT01060371
RATIONALE: Pentostatin may stop the growth of cancer cells by blocking some...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2005-07
Trial ID
NCT00546377
This phase I trial tests the safety, side effects, and best dose of FH-FOLR...
Status
Recruiting
Location
Fred Hutch/University of Washington/Seattle Children's Cancer Consortium
Start Date
2025-02-24
Trial ID
NCT06609928
This early phase I trial tests the safety, side effects and how well medica...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2025-08-12
Trial ID
NCT07025226
The aim of this research is to understand how lipids such as cholesterol af...
Status
Unknown
Location
University College London Hospitals NHS Foundation Trust
Start Date
2018-09-01
Trial ID
NCT04053374
Treatments Being Tested
This phase I/II study is to evaluate the recommended dose, safety, feasibil...
Status
Active Not Recruiting
Location
Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine
Start Date
2025-03-17
Trial ID
NCT06809530
Treatments Being Tested